SALE AND CONTRIBUTION AGREEMENT dated as of February 28, 2020 among THERAVANCE BIOPHARMA R&D, INC., as the Transferor, TRIPLE ROYALTY SUB II LLC, as the Transferee,Sale and Contribution Agreement • March 4th, 2020 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledMarch 4th, 2020 Company Industry Jurisdiction
SALE AND CONTRIBUTION AGREEMENT dated as of November 30, 2018 among THERAVANCE BIOPHARMA R&D, INC., as the Transferor, TRIPLE ROYALTY SUB LLC, as the Transferee, and solely with respect to Articles V and IX and Sections 6.7, 8.2, 8.3 and 8.4,...Sale and Contribution Agreement • December 3rd, 2018 • Theravance Biopharma, Inc. • Pharmaceutical preparations • New York
Contract Type FiledDecember 3rd, 2018 Company Industry JurisdictionThis SALE AND CONTRIBUTION AGREEMENT, dated as of November 30, 2018 (this “Sale and Contribution Agreement”), is entered into among Theravance Biopharma R&D, Inc., a Cayman Islands exempted company (the “Transferor”), Triple Royalty Sub LLC, a Delaware limited liability company (the “Transferee”), and solely with respect to Articles V and IX and Sections 6.7, 8.2, 8.3 and 8.4, Theravance Biopharma, Inc., a Cayman Islands exempted company (“Theravance Biopharma”).